Patient Disease:
Canine Lymphoma
Study Name:
Evaluation of the Phenotypic Characteristics of Lymphoid cells in Dogs Receiving Chemotherapy for Lymphoma
Purposes of the study:
- Evaluate the cell characteristics in the lymph nodes of dogs who have completed chemotherapy and are considered to be in remission based on lymph node palpation
Primary Eligibility Criteria:
- Dogs previously diagnosed with large to intermediate cell multicentric lymphoma
- Has completed standard chemotherapy protocol and is deemed to be in clinical remission based on lymph node palpation
- Had pre-chemotherapy flow cytometry testing performed
- Pets must come to CSU for all visits related to the clinical trial
Study Protocol:
- Dogs will have needle aspirates of lymph nodes performed at one of their standard recheck visits after chemotherapy completion
Owner Responsibilities:
- N/A
Financial Incentives:
- Study will pay for the costs the lymph node aspirates and the tests that are performed on them including flow cytometry and PARR
- No other financial incentives
If you have further questions about any of our clinical trials, please submit an online consult form. Your consult will then be directed to our trials team. Requests are typically returned within 5 business days